MedPath

Prevention of Preterm Birth With a Pessary in Twin Gestations

Not Applicable
Completed
Conditions
Short Cervix
Premature Birth
Interventions
Device: Bioteque cup pessary
Registration Number
NCT02056639
Lead Sponsor
University of Pennsylvania
Brief Summary

Preterm birth (PTB) is a major health problem and contributes to more than 50% of the overall perinatal mortality. Twins are at increased risk for PTB. The number of twins births has risen substantially due to the increased use of assisted reproductive technology. The rate of twin births in the United States rose from 18.9 to 32.2 per 100 live births between 1980 and 2004. The increased rate of PTB in twins is associated with increased morbidity and mortality rates. Almost one in four very low birth-weight infants (below 1500 g) born in the United States are twins, as are one in six infants who die in the first month of life. Cervical shortening is a risk factor for PTB. Transvaginal ultrasound measurement of cervical length is a reliable screening test for prediction of PTB. There is currently no effective treatment to decrease the incidence of PTB in women with twin gestations, but there is some evidence that the use of a cervical pessary in women with a short cervix has promise. If effective this approach would be particularly appealing because of the wide availability of pessaries, ease of use, and low cost. Unfortunately, existing studies are inadequate to confirm effectiveness; a well designed, properly powered, prospective randomized trial is warranted prior to widespread implementation in clinical practice. We propose such a trial to study the effectiveness of the pessary in decreasing the incidence of PTB in an inner city Philadelphia population.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
46
Inclusion Criteria
  • 18-50 years of age
  • Twin pregnancy (limits the participants to female gender)
  • Short cervical length (less than or equal to 30 mm) on second trimester ultrasound at 18-27 6/7 weeks gestation
Read More
Exclusion Criteria
  • Singleton or higher order than twins multiple gestation
  • Monoamniotic twins
  • Twin twin transfusion syndrome
  • Ruptured membranes
  • Lethal fetal structural anomaly
  • Fetal chromosomal abnormality
  • Cerclage in place (or planned placement)
  • Vaginal bleeding
  • Suspicion of chorioamnionitis
  • Ballooning of membranes outside the cervix into the vagina
  • Painful regular uterine contractions
  • Labor
  • Placenta previa
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PessaryBioteque cup pessaryUse of the Bioteque cup pessary. Pessary will be placed between 18 and 27 6/7 weeks gestation, and will be removed during the 36th week of pregnancy (or earlier if indicated)
Primary Outcome Measures
NameTimeMethod
Number of Participants With Preterm DeliveryLess than 34 weeks gestation
Secondary Outcome Measures
NameTimeMethod
Spontaneous Preterm Birth RatesLess than 37 weeks gestation
Number of Participants That Experienced Neonatal DeathBetween birth and 28 days of age

Number of participants that experienced neonatal deaths that occurred in each group following birth was recorded and analyzed.

Number of Subjects Experiencing ChorioamnionitisTime of delivery

Chorioamnionitis was recorded and analyzed for participants in each group.

Average Birth Weight of Babies in Each GroupTime of delivery

The birth weight of babies is the pessary group and no pessary group were recorded and analyzed for comparison.

Trial Locations

Locations (3)

Hospital of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Pennsylvania Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

Thomas Jefferson University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath